Article
ARMC5-CUL3 E3 ligase targets full-length SREBF in adrenocortical tumors.
JCI insight - 22 Aug 2022
Okuno Yosuke, Fukuhara Atsunori, Otsuki Michio, Shimomura Iichiro
Abstract excerpt
Inactivating mutations of ARMC5 are responsible for the development of bilateral macronodular adrenal hyperplasia (BMAH). Although ARMC5 inhibits adrenocortical tumor growth and is considered a tumor-suppressor gene, its molecular function is poorly understood. In this study, through biochemical purification using SREBF (SREBP) as bait, we identified the interaction between SREBF and ARMC5 through its Armadillo...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
